Viewing nowCombinationValsarex Tablet 5/160 mg (Amlodipine, Valsartan)
Amlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.

MFDS item code 201310764 · Approved 2013.12.18 · Insurance code 670606700
Treatment of essential hypertension not controlled with monotherapy
This medication is used for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled by amlodipine or valsartan monotherapy.
The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the drug be taken at the same time each day (e.g.: in the morning), if possible. Before administering this drug, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, direct switching to this drug may be considered if blood pressure is not adequately controlled with monotherapy using the individual components as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this drug should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
Pediatric patients younger than 18 years: Use of this drug is not recommended because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to the active ingredients or similar components, pregnant or breastfeeding women, and those with severe kidney or liver diseases should not take this medication. Caution should be exercised when using this medication in cases of sodium or fluid depletion, hyperkalemia, or abnormalities in renal blood vessels; blood pressure and renal function should be monitored frequently. Patients with heart-related diseases, including heart failure or those recovering from myocardial infarction, or aortic stenosis should also take this medication with caution. As this medication may lower blood pressure, patients may experience hypotension when starting therapy or increasing the dose; if symptoms arise, they should lie down immediately and seek medical attention if necessary. Additionally, this medication can increase potassium levels, so potassium concentrations should be regularly checked when taking it with potassium supplements or drugs rich in potassium. Dizziness or fatigue may occur while driving or operating machinery, so caution is advised. Overdosing on this medication may cause severe hypotension or cardiac arrhythmias; therefore, the dosage guidelines must be strictly followed, and immediate medical attention is required in cases of overdose. Finally, this medication is not recommended for children due to insufficient evidence regarding its safety and efficacy, though elderly patients can take it at the same dosage as adults.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is best kept at room temperature between 1°C and 30°C, away from extreme heat or cold.
Dark yellow, egg-shaped film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.